MedTrace Logo

Hericium Erinaceus Mycelium and Probiotic of the Grape King Bio on Symptoms of Premenstrual Syndrome

NCT05443477 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2022-07-05

No results posted yet for this study

Summary

The purpose of this experiment is to evaluate the efficacy of supplemental health food Grape King Hericium erinaceus Mycelium Capsules and Grape King Probiotic Capsules in improving physical and psychological symptoms, blood oxidative stress and inflammation indicators in women with premenstrual syndrome.

Conditions

  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

Hericium Erinaceus Mycelium

participants received two oral capsules containing Hericium erinaceus Mycelium every day for the 3 months.

DIETARY_SUPPLEMENT

Probiotic

participants received two oral capsules containing Probiotic powder every day for the 3 months.

DIETARY_SUPPLEMENT

control

participants received two oral capsules containing control powder every day for the 3 months.

Sponsors & Collaborators

  • Chung Shan Medical University

    lead OTHER

Principal Investigators

  • Kai-Li Liu, PhD · Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan

  • Man-Jung Hung, MD, PhD · Department of Medicine, Chung Shan Medical University, Taichung, Taiwan

  • Yi-Chin Lin, PhD · Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan

  • Pey-Ling Shieh Shieh, PhD · Department of Psychology, Chung Shan Medical University, Taichung, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2023-01-07
Completion
2023-01-07

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05443477 on ClinicalTrials.gov